help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-0679
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/12/5029    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eriksson, A. L.
Right arrow Articles by Ohlsson, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eriksson, A. L.
Right arrow Articles by Ohlsson, C.
Related Collections
Right arrow Calcium and Bone Metabolism
Right arrow Male Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 12 5029-5037
Copyright © 2006 by The Endocrine Society

SHBG Gene Promoter Polymorphisms in Men Are Associated with Serum Sex Hormone-Binding Globulin, Androgen and Androgen Metabolite Levels, and Hip Bone Mineral Density

A. L. Eriksson, M. Lorentzon, D. Mellström, L. Vandenput, C. Swanson, N. Andersson, G. L. Hammond, J. Jakobsson, A. Rane, E. S. Orwoll, Ö. Ljunggren, O. Johnell, F. Labrie, S. H. Windahl and C. Ohlsson

Center for Bone Research at the Sahlgrenska Academy (A.L.E., M.L., D.M., L.V., C.S., N.A., S.H.W., C.O.), Departments of Internal Medicine and Geriatrics, Göteborg University, SE-413 45 Göteborg, Sweden; Department of Obstetrics and Gynaecology (G.L.H.), University of British Columbia and Child and Family Research Institute, Vancouver, Canada V5Z 4H4; Department of Laboratory Medicine (J.J., A.R.), Division of Clinical Pharmacology, Karolinska Institutet at Karolinska University Hospital, SE-141 86 Stockholm, Sweden; Bone and Mineral Research Unit (E.S.O.), Oregon Health and Sciences University and Portland Veterans Affairs Medical Center, Portland, Oregon 97207; Department of Medical Sciences (Ö.L.), University of Uppsala, SE-751 85 Uppsala, Sweden; Department of Orthopaedics (O.J.), Malmö General Hospital, SE-20502 Malmö, Sweden; and Laboratory of Molecular Endocrinology and Oncology (F.L.), Laval University Hospital Research Center (CRCHUL) and Laval University, Quebec, Canada G1V 4G2

Address all correspondence and requests for reprints to: Claes Ohlsson, Department of Internal Medicine, Division of Endocrinology, Gröna Stråket 8, 413 45 Gothenburg, Sweden. E-mail: claes.ohlsson{at}medic.gu.se.

Context: SHBG regulates free sex steroid levels, which in turn regulate skeletal homeostasis. Twin studies have demonstrated that genetic factors largely account for interindividual variation in SHBG levels. Glucuronidated androgen metabolites have been proposed as markers of androgenic activity.

Objective: Our objective was to investigate whether polymorphisms in the SHBG gene promoter [(TAAAA)n microsatellite and rs1799941 single-nucleotide polymorphism] are associated with serum levels of SHBG, sex steroids, or bone mineral density (BMD) in men.

Design and Study Subjects: We conducted a population-based study of two cohorts of Swedish men: elderly men (MrOS Sweden; n {cong} 3000; average age, 75.4 yr) and young adult men (GOOD study; n = 1068; average age, 18.9 yr).

Main Outcome Measures: We measured serum levels of SHBG, testosterone, estradiol, dihydrotestosterone, 5{alpha}-androstane-3{alpha},17ß-diol glucuronides, androsterone glucuronide, and BMD determined by dual-energy x-ray absorptiometry.

Results: In both cohorts, (TAAAA)n and rs1799941 genotypes were associated with serum levels of SHBG (P < 0.001), dihydrotestosterone (P < 0.05), and 5{alpha}-androstane-3{alpha},17ß-diol glucuronides (P < 0.05). In the elderly men, they were also associated with testosterone and BMD at all hip bone sites. The genotype associated with high levels of SHBG was also associated with high BMD. Interestingly, male mice overexpressing human SHBG had increased cortical bone mineral content in the femur, suggesting that elevated SHBG levels may cause increased bone mass.

Conclusions: Our findings demonstrate that polymorphisms in the SHBG promoter predict serum levels of SHBG, androgens, and glucuronidated androgen metabolites, and hip BMD in men.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
J. S. Lee, A. Z. LaCroix, L. Wu, J. A. Cauley, R. D. Jackson, C. Kooperberg, M. S. Leboff, J. Robbins, C. E. Lewis, D. C. Bauer, et al.
Associations of Serum Sex Hormone-Binding Globulin and Sex Hormone Concentrations with Hip Fracture Risk in Postmenopausal Women
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1796 - 1803.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. Turk, P. Kopp, L. A. Colangelo, M. Urbanek, K. Wood, K. Liu, H. G. Skinner, and S. M. Gapstur
Associations of Serum Sex Hormone Binding Globulin (SHBG) Levels with SHBG Gene Polymorphisms in the CARDIA Male Hormone Study
Am. J. Epidemiol., February 15, 2008; 167(4): 412 - 418.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Khosla
Sex Hormone Binding Globulin: Inhibitor or Facilitator (or Both) of Sex Steroid Action?
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4764 - 4766.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society